Skip to main content
. Author manuscript; available in PMC: 2014 May 2.
Published in final edited form as: Clin Cancer Res. 2012 Sep 17;18(21):6058–6064. doi: 10.1158/1078-0432.CCR-11-3251

Table 3.

Nondose Limiting MLN8237-related toxicity more than grade 1 during cycle 1

Dose level (mg/m2/dose)
45 qd (n = 6) Grade
60 qd (n = 5) Grade
60 divided bid (n = 5) Grade
80 qd (n = 6) Grade
80 divided bid (n = 6) Grade
100 qd (n = 4) Grade
Toxicity type 2 3 4 2 3 4 2 3 4 2 3 4 2 3 4 2 3 4
Hematologic
    Anemia 2 1 3 1 2 1 1 3 1
    Leukopenia 3 1 1 4 2 3 4 2 1 1
    Lymphopenia 2 1 1 3 1 1 2 1 3 2
    Neutropenia 2 1 1 1 1 1 3 1 1 3 1 3 2
    Thrombocytopenia 1 1 1 2 1
Constitutional
    Fatigue 1 1
    Fever 1
Dermatology
    Alopecia 1 2 3 1
    Rash/desquamation 1 2 1
    Hand–foot–skin reaction 1 1
Gastrointestinal
    Anorexia 1 1
    Diarrhea 1
    Mucositis/stomatitis 1 1 2 3 1
    Nausea 1
    Vomiting 1
Infection
    Febrile neutropenia 1 1 2 1
    Infection 1
Metabolic/lab
    Alkaline phosphatase 1
    ALT 1 1
    AST 1 1
    Hyperbilirubinemia 1
    Hypocalcemia 1 1
    Gamma glutamyl transpeptidase 1
    Hypophosphatemia 2 1
    Hypokalemia 1
    Hyponatremia 1
    Other metabolic 1
Neurology
    Memory impairment 1
    Mood alteration agitation 1
    Euphoria 1
    Somnolence 2 1 1 1
Ocular
    Flashing lights/floaters 1
    Photophobia 1
Pain
    Pain abdomen NOS 1
    Pain extremity 1
    Pain eye 1
    Pain joint 1
    Pain oral cavity 1

Abbreviations: AST, aspartate aminotransferase; NOS, nitric oxide synthase.